Hot Pursuit     18-Jan-25
Rallis India PAT slumps 54% YoY to Rs 11 crore in Q3 FY25
The pesticides maker reported 54.17% drop in net profit to Rs 11 crore on 12.71% slide in revenue from operations to Rs 522 crore in Q3 FY25 over Q3 FY24.
The company said that profitablity was impacted due to lower EBITDA.

In third quarter of FY25, profit before tax stood at Rs 19 crore, registering a de-growth of 36.67% on YoY basis.

EBITDA declined 27% YoY to Rs 44 crore in the December 2024 quarter, due to volume drop and pricing pressure in exports impacted margins.

Revenue from Crop care declined 13% YoY to Rs 492 crore in Q3 FY25. Domestic Crop care volumes were up by 2.5% in Q3 FY25 while exports volumes fell by 34% due to weak demand.

Revenue from Seeds slipped 7% YoY to Rs 30 crore during the quarter, largely due to drop in hybrid mustard market demand.

On nine-month basis, the company’s net profit shed 7.1% to Rs 157 crore on 0.95% rise in revenue from operations to Rs 2,233 crore in 9M FY25 over 9M FY24.

Dr. Gyanendra Shukla, managing director & CEO, Rallis India, said, “Domestic business registered volume growth in the backdrop of intense market competition. I am pleased with the growth in Biologicals & Specialty solutions business, which has grown by 13%. Seeds business revenue was Rs 30 crore as against Rs 32 crore in Q3 PY. Exports business continues to face headwinds with business registering a de-growth of 38% resulting in overall revenue de-growth of 13% and drop in profitability .

Our efforts will continue to be focused on improving market share in the domestic business underpinned by the growing segments of Seeds, Herbicides and Biologicals & Specialty solutions. We have planned new differentiated product launches to serve the varying needs of farmers. In Seeds business, our teams are working for the upcoming Kharif season.

We are also in the final stages of commercializing a new active ingredient ‘Metalaxyl-M’ and are confident of the long-term potential of the product both for domestic and international markets. We will intensify the actions around expansion of our customer base and deepening strategic partnerships.

We have commenced actions to refresh our talent base in key positions. Our efforts to significantly improve engagement with farmers resting on the digital platform have been initiated. Sustainability is an integral part, and we remain committed to a greener future.”

Rallis India is a subsidiary of Tata Chemicals and a part of the US$ 165 billion Tata Group. It is one of India’s leading agro sciences companies, with more than 75 years of experience of servicing rural markets with the most comprehensive portfolio of products/solutions for Indian farmers. It has marketing alliances with several multinational agrochemical companies.

The scrip closed 0.52% higher at Rs 289.75 on Friday, 18 January 2025.

Previous News
  Rallis India
 ( Results - Analysis 20-Jan-22   08:30 )
  Indices nudge lower; breadth strong
 ( Market Commentary - Mid-Session 16-Oct-24   09:33 )
  Rallis India drops as PAT slumps 54% YoY to Rs 11 crore in Q3 FY25
 ( Hot Pursuit - 20-Jan-25   10:07 )
  Rallis India to hold AGM
 ( Corporate News - 21-May-24   12:09 )
  Rallis India standalone net profit rises 9.09% in the December 2023 quarter
 ( Results - Announcements 23-Jan-24   17:44 )
  CRISIL Ratings reaffirms Rallis India's 'AA+' with 'stable' outlook
 ( Hot Pursuit - 24-Sep-24   14:19 )
  Rallis India to conduct board meeting
 ( Corporate News - 09-Oct-21   10:12 )
  Rallis India schedules board meeting
 ( Corporate News - 12-Jul-22   14:02 )
  Rallis India
 ( Analyst Meet / AGM - Conference Call 19-Jan-21   16:02 )
  Rallis India standalone net profit rises 25.89% in the September 2022 quarter
 ( Results - Announcements 19-Oct-22   17:56 )
  Rallis India sizzles after robust Q1 result
 ( Hot Pursuit - 23-Jul-20   09:18 )
Other Stories
  Shipping Corp Q3 PAT drops 44% YoY to Rs 76 cr
  08-Feb-25   15:44
  Honeywell Automation PAT rises 3% YoY to Rs 132 cr in Q3
  08-Feb-25   14:35
  Oil India Q3 PAT slides 23% YoY to Rs 1,222 crore
  08-Feb-25   13:01
  Delhivery Q3 PAT climbs 113% YoY to Rs 25 cr
  08-Feb-25   11:56
  LIC Q3 PAT rises 17% YoY to Rs 11,056 cr
  08-Feb-25   11:12
  Fortis Healthcare Q3 PAT climbs 84% YoY to Rs 248 cr
  08-Feb-25   08:59
  Balrampur Chini declines as Q3 PAT slides 23% YoY to Rs 70 crore
  07-Feb-25   16:55
  NOCIL slumps after Q3 PAT slips 57% YoY to Rs 13 crore
  07-Feb-25   16:15
  Bikaji Foods slides as Q3 PAT drops 39% YoY to Rs 29 cr
  07-Feb-25   15:35
  DCX Systems drops after Q3 PAT slides 25% YoY to Rs 10 crore
  07-Feb-25   15:34
Back Top